A detailed history of Goelzer Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Goelzer Investment Management, Inc. holds 546,870 shares of LLY stock, worth $435 Million. This represents 26.7% of its overall portfolio holdings.

Number of Shares
546,870
Previous 568,329 3.78%
Holding current value
$435 Million
Previous $515 Million 5.84%
% of portfolio
26.7%
Previous 28.8%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $16.6 Million - $20.6 Million
-21,459 Reduced 3.78%
546,870 $484 Million
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $10.9 Million - $13.7 Million
-15,072 Reduced 2.58%
568,329 $515 Million
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $3.49 Million - $4.66 Million
-5,886 Reduced 1.0%
583,401 $454 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $31.1 Million - $36.6 Million
-59,135 Reduced 9.12%
589,287 $344 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $244 Million - $336 Million
561,464 Added 645.67%
648,422 $348 Million
Q2 2023

Jul 26, 2023

SELL
$350.74 - $468.98 $46,648 - $62,374
-133 Reduced 0.15%
86,958 $40.8 Million
Q1 2023

Apr 27, 2023

BUY
$310.63 - $364.82 $91,325 - $107,257
294 Added 0.34%
87,091 $29.9 Million
Q4 2022

Jan 20, 2023

BUY
$321.55 - $374.67 $85,210 - $99,287
265 Added 0.31%
86,797 $0
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $66,411 - $75,682
224 Added 0.26%
86,532 $28 Million
Q2 2022

Aug 01, 2022

SELL
$278.73 - $327.27 $214,064 - $251,343
-768 Reduced 0.88%
86,308 $28 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $94,580 - $117,538
-403 Reduced 0.46%
87,076 $24.9 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $422,268 - $524,037
1,878 Added 2.19%
87,479 $24.2 Million
Q3 2021

Oct 29, 2021

SELL
$221.6 - $272.71 $3.55 Million - $4.37 Million
-16,017 Reduced 15.76%
85,601 $19.8 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $595,273 - $769,981
-3,297 Reduced 3.14%
101,618 $23.3 Million
Q1 2021

May 06, 2021

SELL
$164.32 - $212.72 $976,225 - $1.26 Million
-5,941 Reduced 5.36%
104,915 $19.6 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $26.3 Million - $34.8 Million
-201,334 Reduced 64.49%
110,856 $18.7 Million
Q3 2020

Oct 27, 2020

SELL
$146.22 - $169.13 $20,617 - $23,847
-141 Reduced 0.05%
312,190 $46.2 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $223,865 - $269,419
1,641 Added 0.53%
312,331 $51.3 Million
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $10,595 - $13,114
89 Added 0.03%
310,690 $43.1 Million
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $96,228 - $119,187
-900 Reduced 0.29%
310,601 $40.8 Million
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $64,074 - $69,696
-600 Reduced 0.19%
311,501 $34.8 Million
Q2 2019

Jul 29, 2019

SELL
$110.79 - $129.32 $5,539 - $6,466
-50 Reduced 0.02%
312,101 $34.6 Million
Q1 2019

May 03, 2019

BUY
$111.31 - $131.02 $32.3 Million - $38.1 Million
290,557 Added 1345.55%
312,151 $40.5 Million
Q4 2018

Jan 28, 2019

SELL
$105.9 - $118.64 $114,054 - $127,775
-1,077 Reduced 4.75%
21,594 $2.5 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $242,726 - $303,365
-2,827 Reduced 11.09%
22,671 $2.43 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $250,718 - $287,746
-3,312 Reduced 11.5%
25,498 $2.18 Million
Q1 2018

May 07, 2018

SELL
$74.21 - $87.6 $114,802 - $135,517
-1,547 Reduced 5.1%
28,810 $2.23 Million
Q4 2017

Feb 06, 2018

BUY
$81.94 - $87.89 $629,790 - $675,522
7,686 Added 33.9%
30,357 $2.56 Million
Q3 2017

Oct 31, 2017

BUY
$77.07 - $85.54 $1.75 Million - $1.94 Million
22,671
22,671 $1.94 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Goelzer Investment Management, Inc. Portfolio

Follow Goelzer Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Goelzer Investment Management, Inc. with notifications on news.